Share

P-Value Workshop

Brussels, 19 December 2025 

On 9 December, EORTC hosted the second P-value Workshop, and welcomed over 250 participants online from over 43 countries.

The workshop, marking 100 years of the 5% p-value cutoff, was a great opportunity to exchange views on how we define scientific evidence today. Discussions highlighted the continued relevance of p-values, while also emphasising the need to avoid relying on them in isolation.

Speakers and participants explored how decision-making in clinical research should be informed by a balanced assessment of benefits and risks, supported by reliable estimates, and how future guidelines could help shape a more nuanced and meaningful approach to evidence-based research.

The discussions were insightful and engaging. A big thank you to our speakers for their valuable contributions, and to everyone who joined and shared their perspectives. A full report will be shared in due course capturing the key insights from these conversations.

Back to news list

Related News

  • Pink October 2026: Advancing breast cancer research, together

  • EORTC presents new results in neuro-oncology at EANO

  • In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group

  • New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults

  • New EORTC questionnaire sets a global standard for measuring quality of life in cancer survivors

  • EORTC calls for a balanced and feasible European Health Data Space (EHDS)

  • Professor Benjamin Besse becomes President of EORTC

  • CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer

  • EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials

  • New study confirms a key quality of life tool can be used with adolescents with cancer